Citigroup
SBC icon

Citigroup’s SBC Medical Group SBC Stock Holding History

Citigroup’s Portfolio SBC Stock Details SBC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.5K Sell
2,540
-6,390
-72% -$23.9K ﹤0.01% 5133
2026
Q2 		$27.5K Buy
8,930
+8,336
+1,403% +$28.3K ﹤0.01% 5104
2026
Q1 		$2.48K Buy
594
+339
+133% +$1.41K ﹤0.01% 5399
2025
Q4 		$1.1K Buy
255
+179
+236% +$683 ﹤0.01% 5539
2025
Q3 		$329 Sell
76
-1,825
-96% -$8.23K ﹤0.01% 5737
2025
Q2 		$8.82K Buy
+1,901
New +$7.52K ﹤0.01% 5209

Other funds holding SBC

Lumbard & Kellner
Lumbard & Kellner Hollis, New Hampshire $352M AUM 38.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Hillsdale Investment Management
Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Citigroup's SBC Position: Q3 2026 in Review

Citigroup reduced its SBC Medical Group (SBC) stake by 72% in Q3 2026, selling an estimated $23.9K and leaving 2,540 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5133.

Citigroup first reported a position in SBC in Q2 2025 and has held it in 6 quarters since. The position peaked at $27.5K in Q2 2026. 51 funds tracked by Wall St. Rank hold SBC as of Q3 2026.

  • Citigroup held 2,540 shares of SBC Medical Group worth $12.5K as of Q3 2026.
  • Citigroup sold 6,390 SBC Medical Group shares in Q3 2026, an estimated $23.9K.
  • SBC Medical Group made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5133 holding.
  • Citigroup first reported a position in SBC Medical Group in Q2 2025 and has held it in 6 quarters since.
  • Citigroup's SBC Medical Group position peaked at $27.5K in Q2 2026.
  • 51 funds tracked by Wall St. Rank held SBC Medical Group as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.